Ironwood Pharmaceuticals | Omløpsmidler



Current Assets Endring Dato
Acadia Pharmaceuticals USD 938.32M 150.03M 2024-12
Agios Pharmaceuticals USD 968.62M 3.02M 2025-03
Almirall EUR 693.24M 29.14M 2024-06
Alnylam Pharmaceuticals USD 3.27B 27.03M 2025-03
Amarin USD 650.22M 51.62M 2024-09
Ardelyx USD 356.45M 72.35M 2024-12
Astellas Pharma JPY 1.2T 2.56B 2025-03
AstraZeneca USD 26.14B 312M 2025-03
Charles River Laboratories USD 1.4B 91.65M 2024-12
Exact Sciences USD 1.37B 201.08M 2025-03
Halozyme Therapeutics USD 1.26B 176.69M 2025-03
Incyte USD 3.23B 7.24M 2025-03
Ironwood Pharmaceuticals USD 182.42M 3.81M 2024-12
MacroGenics USD 217.49M 4.71M 2024-12
Moderna USD 6.77B 1.33B 2025-03
Myriad Genetics USD 298M 4.8M 2024-12
Pacira USD 745.13M 55.16M 2024-12
PTC Therapeutics USD 1.37B 83.98M 2024-12
Sarepta Therapeutics USD 3.07B 388.09M 2024-12
Takeda JPY 2.75T 299.73B 2024-12
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12



Ironwood Pharmaceuticals Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.